国邦医药

605507 SSE 证监会行业分类 C27医药制造业

Key Metrics

Market Cap

14.7B ($2.1B)

P/E Ratio

N/A

P/B Ratio

N/A

Revenue

5.9B

Net Income

781.0M

Gross Margin

N/A

Op. Margin

15.2%

Net Margin

13.3%

ROE

9.7%

ROA

7.2%

D/E

0.34

Dividend Yield

N/A

EPS

1.40

Current Ratio

2.30

Price History

Company Info

Industry	C27医药制造业
Market Segment	Main Board
Currency	CNY
Fiscal Year	2024

Business Overview

Guobang Pharma Ltd. engages in the research, development, production, and sale of products in the pharmaceutical and veterinary industries. The company offers pharmaceutical products, including quinolones, macrolides, cephalosporins, characteristic APIs, preparations and accessories, and key pharmaceutical intermediates; and mobile protection APIs, kinetophoretic preparations, and feed additives. It sells its products approximately in 115 countries and regions worldwide. Guobang Pharma Ltd. was founded in 1996 and is based in Xinchang, China.

Full Financials Advanced Charts Filings

Peers

工商银行

601398

2.7T

P/E: 7.6

建设银行

601939

2.5T

P/E: 7.2

农业银行

601288

2.4T

P/E: 8.7

中国海油

600938

2.0T

P/E: 16.2

宁德时代

300750

1.9T

P/E: 25.6

贵州茅台

600519

1.8T

P/E: 20.1

中国银行

601988

1.8T

P/E: 7.3

中国人寿

601628

1.2T

P/E: 6.9

Financial Statements

Loading financials...

Open Advanced Charts

Full charting with technical indicators, candlestick, and more.

About 国邦医药

Ticker	605507
Exchange	SSE
Sector	证监会行业分类
Industry	C27医药制造业